Similar articles

• The treatment of Cooley's anemia.

  Nathan DG. Nathan DG. Haematologica. 1990 Sep-Oct;75 Suppl 5:57-65. Haematologica. 1990. PMID: 2086382 Review. No abstract available.
• Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.

  Giardina PJ, Grady RW. Giardina PJ, et al. Semin Hematol. 1995 Oct;32(4):304-12. Semin Hematol. 1995. PMID: 8560288 Review.
• Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.

  Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC. Cooper B, et al. Trans Assoc Am Physicians. 1977;90:335-41. Trans Assoc Am Physicians. 1977. PMID: 611665 No abstract available.
• Iron metabolism and iron chelation in the thalassaemia disorders.

  Pippard MJ. Pippard MJ. Haematologica. 1990 Sep-Oct;75 Suppl 5:66-71. Haematologica. 1990. PMID: 2086383 Review. No abstract available.
• [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].

  Krüger N, Kijewski H, König R, Tillmann W, Schröter W. Krüger N, et al. Dtsch Med Wochenschr. 1984 Nov 2;109(44):1682-5. doi: 10.1055/s-2008-1069435. Dtsch Med Wochenschr. 1984. PMID: 6489181 German.